Overview

Description

  • NatureSynthetic
  • Amino Acid Sequence
    • SpeciesHuman
    • SequenceC-PANSQSRMSTNM
    • Amino acids480 to 491

Associated products

Specifications

Our Abpromise guarantee covers the use of ab23045 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

  • Applications

    Blocking - Blocking peptide for Anti-CSN1 antibody (ab4535)

  • FormLiquid
  • Concentration information loading...

Preparation and Storage

  • Stability and Storage

    Shipped at 4°C. Upon delivery aliquot and store at -20°C or -80°C. Avoid repeated freeze / thaw cycles.

General Info

  • Alternative names
    • COP9 signalosome complex subunit 1
    • COP9 signalosome subunit 1
    • COPS1
    • CSN 1
    • CSN1_HUMAN
    • FUS6/COP11, Arabidopsis, homolog of
    • G protein pathway suppressor 1
    • GPS-1
    • Gps1
    • JAB1-containing signalosome subunit 1
    • Protein GPS1
    • Protein MFH
    • SGN1
    • Signalosome subunit 1
    see all
  • FunctionEssential component of the COP9 signalosome complex (CSN), a complex involved in various cellular and developmental processes. The CSN complex is an essential regulator of the ubiquitin (Ubl) conjugation pathway by mediating the deneddylation of the cullin subunits of SCF-type E3 ligase complexes, leading to decrease the Ubl ligase activity of SCF-type complexes such as SCF, CSA or DDB2. The complex is also involved in phosphorylation of p53/TP53, c-jun/JUN, IkappaBalpha/NFKBIA, ITPK1 and IRF8/ICSBP, possibly via its association with CK2 and PKD kinases. CSN-dependent phosphorylation of TP53 and JUN promotes and protects degradation by the Ubl system, respectively. Suppresses G-protein-and mitogen-activated protein kinase-mediated signal transduction.
  • Tissue specificityWidely expressed.
  • Sequence similaritiesBelongs to the CSN1 family.
    Contains 1 PCI domain.
  • DomainThe PCI domain is necessary and sufficient for the interactions with other CSN subunits of the complex. Mediates the interaction with CAPN8.
    The N-terminal part (1-216), which is not required for deneddylating activity and CSN complex formation, is nevertheless essential for other aspects of CSN complex function, such as repression of c-fos/FOS expression.
  • Post-translational
    modifications
    Phosphorylated upon DNA damage, probably by ATM or ATR.
  • Cellular localizationCytoplasm. Nucleus.
  • Information by UniProt

References for Human CSN1 peptide (ab23045)

ab23045 has not yet been referenced specifically in any publications.

Product Wall

There are currently no Abreviews or Questions for ab23045.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"